At the time of writing, Evolent Health Inc [EVH] stock is trading at $26.80, up 2.02%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EVH shares have gain 2.49% over the last week, with a monthly amount drifted -11.11%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on August 09, 2024, when Truist upgraded its rating to a Buy and also boosted its price target to $33 from $28. Previously, Citigroup started tracking the stock with Buy rating on April 22, 2024, and set its price target to $40. On March 01, 2024, Oppenheimer initiated with a Outperform rating and assigned a price target of $45 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $39 on January 03, 2024. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $37 as its price target on December 06, 2023. UBS started tracking with a Buy rating for this stock on October 16, 2023, and assigned it a price target of $46. In a note dated April 12, 2023, Stephens initiated an Overweight rating and provided a target price of $40 on this stock.
For the past year, the stock price of Evolent Health Inc fluctuated between $17.98 and $35.00. Currently, Wall Street analysts expect the stock to reach $44 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $26.80 at the most recent close of the market. An investor can expect a potential return of 64.18% based on the average EVH price forecast.
Analyzing the EVH fundamentals
According to Evolent Health Inc [NYSE:EVH], the company’s sales were 2.35B for trailing twelve months, which represents an 37.94% jump. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.07 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.22 points at the first support level, and at 25.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.20, and for the 2nd resistance point, it is at 27.59.
Ratios To Look Out For
It is important to note that Evolent Health Inc [NYSE:EVH] has a current ratio of 1.08. In addition, the Quick Ratio stands at 1.08 and the Cash Ratio stands at 0.25. Considering the valuation of this stock, the price to sales ratio is 1.32, the price to book ratio is 2.92.
Transactions by insiders
Recent insider trading involved McCarthy Daniel Joseph, PRESIDENT, that happened on Aug 22 ’24 when 23693.0 shares were sold. PRESIDENT, McCarthy Daniel Joseph completed a deal on Aug 23 ’24 to sell 10469.0 shares. Meanwhile, General Counsel Weinberg Jonathan sold 42140.0 shares on Aug 22 ’24.
